Last reviewed · How we verify

NCT05441696

Study for the Evaluation of a Non-invasive Hemodynamic Measurement in Heart Failure Patients

ENROLLING BY INVITATION Last updated 27 December 2024
What this trial tests

trial testing ezCVP measurement in Congestive Heart Failure in 65 participants. Enrolling by invitation.

Timeline
1 June 2022
Primary endpoint
30 September 2025
29 September 2026

Quick facts

Lead sponsorNihon Kohden
StatusENROLLING BY INVITATION
Study typeOBSERVATIONAL
Enrollment65
Start date1 June 2022
Primary completion30 September 2025
Estimated completion29 September 2026
Sites2 locations across United States

Drugs / interventions tested

Conditions studied

Sponsor

Nihon Kohden — full company profile →

Who can join

18 and older, any sex, with Congestive Heart Failure. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Track changes in non-invasive central venous pressure across hospital stay and relationship with readmission

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Congestive Heart Failure

Currently open trials in the same condition.

Other Nihon Kohden trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05441696.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing